Comparison of the efficacy and safety of therapy for multiple myeloma with the inclusion of thalidomide analogues and proteosome inhibitors

For citation: Kaliberdenko V.B., Konishcheva V.S., Emirveli S.M., Stepannikova A.R., Kalafatova N.E., Zopunian L.A., Kapsuzian D.G., Ametova L.O. Comparison of the efficacy and safety of therapy for multiple myeloma with the inclusion of thalidomide analogues and proteosome inhibitors. Clinical review for general practice. 2025; 6 (12): 50–55 (In Russ.). DOI: 10.47407/kr2025.6.12.00730

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.